✦ LIBER ✦

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)

✍ Scribed by M. Baumann; T. Herrmann; R. Koch; W. Matthiessen; S. Appold; B. Wahlers; L. Kepka; G. Marschke; D. Feltl; R. Fietkau; V. Budach; J. Dunst; R. Dziadziuszko; M. Krause; D. Zips

Book ID: 118498049
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 465 KB
Volume: 100
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2011.06.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The final results of a randomized phase

The final results of a randomized phase III trial comparing irinotecan (CPT-11) and cisplatin (CDDP) with vindesine (VDS) and CDDP in advanced non-small cell lung cancer (NSCLC)

✍ Takiguchi, Y; Nagao, K; Nishiwaki, Y; Yokoyama, A; Saijo, N; Ohashi, Y; Niitani, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Randomized phase III trial compared cisp

Randomized phase III trial compared cisplatin and irinotecan (CPT-P) versus cisplatin and vindesine (VDS-P) versus irinotecan alone (CPT) in patients with advanced non-small cell lung cancer (NSCLC) — The final report

✍ Komiya, T; Fukuoka, M; Negoro, S; Masuda, N; Takada, Y; Sugiura, T; Ohashi, Y; N 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

O-085 Phase III trial of the protein kin

O-085 Phase III trial of the protein kinase C α (PKCα) antisense oligonucleotide Aprinocarsen plus gemcitabine/cisplatin versus gemcitabine/cisplatin alone in advanced stage non-small cell lung cancer (NSCLC): Updated results of a randomized phase III trial

✍ Gandara, D.; Douillard, J.; Koralewski, P.; Manegold, C.; Smit, E.; Reyes, J.; C 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Randomized phase III trial of the Southe

Randomized phase III trial of the Southern Italy Oncology Group comparing sequential ifosfamide + gemcitabine followed by cisplatin + navelbine (IG -> PN) versus the opposite sequence (PN -> IG) versus cisplatin + navelbine (PN) versus gemcitabine + cisplatin (GP) in stage III–IV non small cell lung cancer (NSCLC)

✍ Gebbia, V; Galetta, D; Caruso, M; Borsellino, N; Varvara, F; Tirrito, M; Testa, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

P-554 Randomized Phase II study of first

P-554 Randomized Phase II study of first-line docetaxel (D)/ gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC)—Final Results. A study by the NSW and Australian Lung Cancer Trials Group

✍ Pavlakis, N.; McCowatt, S.; Lewis, C.; Marx, G.; Abell, F.; Della-Fiorentina, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB